AK Medical Holdings Limited (1789.HK)
- Previous Close
5.540 - Open
5.410 - Bid 5.720 x --
- Ask 5.770 x --
- Day's Range
5.410 - 5.820 - 52 Week Range
3.890 - 10.800 - Volume
1,852,000 - Avg. Volume
3,075,979 - Market Cap (intraday)
6.473B - Beta (5Y Monthly) -0.77
- PE Ratio (TTM)
33.94 - EPS (TTM)
0.170 - Earnings Date Mar 27, 2024
- Forward Dividend & Yield 0.05 (0.78%)
- Ex-Dividend Date Jun 24, 2024
- 1y Target Est
8.22
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.
www.ak-medical.netRelated News
Performance Overview: 1789.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1789.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1789.HK
Valuation Measures
Market Cap
6.47B
Enterprise Value
5.78B
Trailing P/E
33.37
Forward P/E
22.22
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.46
Price/Book (mrq)
2.50
Enterprise Value/Revenue
5.28
Enterprise Value/EBITDA
27.33
Financial Highlights
Profitability and Income Statement
Profit Margin
16.65%
Return on Assets (ttm)
4.58%
Return on Equity (ttm)
7.86%
Revenue (ttm)
1.09B
Net Income Avi to Common (ttm)
182.1M
Diluted EPS (ttm)
0.170
Balance Sheet and Cash Flow
Total Cash (mrq)
813.88M
Total Debt/Equity (mrq)
3.52%
Levered Free Cash Flow (ttm)
--
Research Analysis: 1789.HK
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 1789.HK
1789.HK does not have Company Insights